A portable graphical link to your paper (QR code) is provided below. If the code is placed, for example, on a poster, your paper can be accessed through a mobile device's QR code reader.

Right click on the image below to save it to your device.

QR Code for 10.1101/2022.11.04.22281950

A non-randomized, open-label, dose-finding, first-in-human trial of combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: transgene expression persists up to 17 months post-vector injection.